Food & Beverages
Global Bifidus Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 04, 25
- ID: 534755
- Pages: 152
- Figures: 165
- Views: 9
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bifidus market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Chr-Hansen
DuPont
Wecare Probiotics
Probi
Mitushi Bio Pharma
Scitop Bio-tech
Lallemand
Goerlich Pharma
Shandong Zhongke Jiayi Bioengineering
Danone
Shanghai SPH Sinopharm
Segment by Type
Food Grade
Pharmaceutical Grade
Segment by Application
Food & Beverages
Medicines
Health Products
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Bifidus study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bifidus market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Chr-Hansen
DuPont
Wecare Probiotics
Probi
Mitushi Bio Pharma
Scitop Bio-tech
Lallemand
Goerlich Pharma
Shandong Zhongke Jiayi Bioengineering
Danone
Shanghai SPH Sinopharm
Segment by Type
Food Grade
Pharmaceutical Grade
Segment by Application
Food & Beverages
Medicines
Health Products
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Bifidus study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Bifidus: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bifidus Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.3 Market Segmentation by Application
1.3.1 Global Bifidus Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food & Beverages
1.3.3 Medicines
1.3.4 Health Products
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bifidus Revenue Estimates and Forecasts 2020-2031
2.2 Global Bifidus Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Bifidus Sales Estimates and Forecasts 2020-2031
2.4 Global Bifidus Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Bifidus Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Bifidus Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Food Grade Market Size by Manufacturers
3.5.2 Pharmaceutical Grade Market Size by Manufacturers
3.6 Global Bifidus Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bifidus Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Bifidus Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bifidus Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Bifidus Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Bifidus Sales and Revenue by Type (2020-2031)
6.4 North America Bifidus Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bifidus Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Bifidus Sales and Revenue by Type (2020-2031)
7.4 Europe Bifidus Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bifidus Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Bifidus Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Bifidus Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Bifidus Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Bifidus Sales and Revenue by Type (2020-2031)
9.4 Central and South America Bifidus Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bifidus Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Bifidus Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Bifidus Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bifidus Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Chr-Hansen
11.1.1 Chr-Hansen Corporation Information
11.1.2 Chr-Hansen Business Overview
11.1.3 Chr-Hansen Bifidus Product Models, Descriptions and Specifications
11.1.4 Chr-Hansen Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Chr-Hansen Bifidus Sales by Product in 2024
11.1.6 Chr-Hansen Bifidus Sales by Application in 2024
11.1.7 Chr-Hansen Bifidus Sales by Geographic Area in 2024
11.1.8 Chr-Hansen Bifidus SWOT Analysis
11.1.9 Chr-Hansen Recent Developments
11.2 DuPont
11.2.1 DuPont Corporation Information
11.2.2 DuPont Business Overview
11.2.3 DuPont Bifidus Product Models, Descriptions and Specifications
11.2.4 DuPont Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 DuPont Bifidus Sales by Product in 2024
11.2.6 DuPont Bifidus Sales by Application in 2024
11.2.7 DuPont Bifidus Sales by Geographic Area in 2024
11.2.8 DuPont Bifidus SWOT Analysis
11.2.9 DuPont Recent Developments
11.3 Wecare Probiotics
11.3.1 Wecare Probiotics Corporation Information
11.3.2 Wecare Probiotics Business Overview
11.3.3 Wecare Probiotics Bifidus Product Models, Descriptions and Specifications
11.3.4 Wecare Probiotics Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Wecare Probiotics Bifidus Sales by Product in 2024
11.3.6 Wecare Probiotics Bifidus Sales by Application in 2024
11.3.7 Wecare Probiotics Bifidus Sales by Geographic Area in 2024
11.3.8 Wecare Probiotics Bifidus SWOT Analysis
11.3.9 Wecare Probiotics Recent Developments
11.4 Probi
11.4.1 Probi Corporation Information
11.4.2 Probi Business Overview
11.4.3 Probi Bifidus Product Models, Descriptions and Specifications
11.4.4 Probi Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Probi Bifidus Sales by Product in 2024
11.4.6 Probi Bifidus Sales by Application in 2024
11.4.7 Probi Bifidus Sales by Geographic Area in 2024
11.4.8 Probi Bifidus SWOT Analysis
11.4.9 Probi Recent Developments
11.5 Mitushi Bio Pharma
11.5.1 Mitushi Bio Pharma Corporation Information
11.5.2 Mitushi Bio Pharma Business Overview
11.5.3 Mitushi Bio Pharma Bifidus Product Models, Descriptions and Specifications
11.5.4 Mitushi Bio Pharma Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Mitushi Bio Pharma Bifidus Sales by Product in 2024
11.5.6 Mitushi Bio Pharma Bifidus Sales by Application in 2024
11.5.7 Mitushi Bio Pharma Bifidus Sales by Geographic Area in 2024
11.5.8 Mitushi Bio Pharma Bifidus SWOT Analysis
11.5.9 Mitushi Bio Pharma Recent Developments
11.6 Scitop Bio-tech
11.6.1 Scitop Bio-tech Corporation Information
11.6.2 Scitop Bio-tech Business Overview
11.6.3 Scitop Bio-tech Bifidus Product Models, Descriptions and Specifications
11.6.4 Scitop Bio-tech Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Scitop Bio-tech Recent Developments
11.7 Lallemand
11.7.1 Lallemand Corporation Information
11.7.2 Lallemand Business Overview
11.7.3 Lallemand Bifidus Product Models, Descriptions and Specifications
11.7.4 Lallemand Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Lallemand Recent Developments
11.8 Goerlich Pharma
11.8.1 Goerlich Pharma Corporation Information
11.8.2 Goerlich Pharma Business Overview
11.8.3 Goerlich Pharma Bifidus Product Models, Descriptions and Specifications
11.8.4 Goerlich Pharma Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Goerlich Pharma Recent Developments
11.9 Shandong Zhongke Jiayi Bioengineering
11.9.1 Shandong Zhongke Jiayi Bioengineering Corporation Information
11.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview
11.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Product Models, Descriptions and Specifications
11.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments
11.10 Danone
11.10.1 Danone Corporation Information
11.10.2 Danone Business Overview
11.10.3 Danone Bifidus Product Models, Descriptions and Specifications
11.10.4 Danone Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Danone Recent Developments
11.11 Shanghai SPH Sinopharm
11.11.1 Shanghai SPH Sinopharm Corporation Information
11.11.2 Shanghai SPH Sinopharm Business Overview
11.11.3 Shanghai SPH Sinopharm Bifidus Product Models, Descriptions and Specifications
11.11.4 Shanghai SPH Sinopharm Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Shanghai SPH Sinopharm Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Bifidus Industry Chain
12.2 Bifidus Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Bifidus Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Bifidus Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bifidus Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bifidus Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Bifidus: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bifidus Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.3 Market Segmentation by Application
1.3.1 Global Bifidus Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food & Beverages
1.3.3 Medicines
1.3.4 Health Products
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bifidus Revenue Estimates and Forecasts 2020-2031
2.2 Global Bifidus Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Bifidus Sales Estimates and Forecasts 2020-2031
2.4 Global Bifidus Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Bifidus Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Bifidus Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Food Grade Market Size by Manufacturers
3.5.2 Pharmaceutical Grade Market Size by Manufacturers
3.6 Global Bifidus Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bifidus Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Bifidus Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bifidus Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Bifidus Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Bifidus Sales and Revenue by Type (2020-2031)
6.4 North America Bifidus Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bifidus Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Bifidus Sales and Revenue by Type (2020-2031)
7.4 Europe Bifidus Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bifidus Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Bifidus Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Bifidus Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Bifidus Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Bifidus Sales and Revenue by Type (2020-2031)
9.4 Central and South America Bifidus Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bifidus Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Bifidus Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Bifidus Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bifidus Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Chr-Hansen
11.1.1 Chr-Hansen Corporation Information
11.1.2 Chr-Hansen Business Overview
11.1.3 Chr-Hansen Bifidus Product Models, Descriptions and Specifications
11.1.4 Chr-Hansen Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Chr-Hansen Bifidus Sales by Product in 2024
11.1.6 Chr-Hansen Bifidus Sales by Application in 2024
11.1.7 Chr-Hansen Bifidus Sales by Geographic Area in 2024
11.1.8 Chr-Hansen Bifidus SWOT Analysis
11.1.9 Chr-Hansen Recent Developments
11.2 DuPont
11.2.1 DuPont Corporation Information
11.2.2 DuPont Business Overview
11.2.3 DuPont Bifidus Product Models, Descriptions and Specifications
11.2.4 DuPont Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 DuPont Bifidus Sales by Product in 2024
11.2.6 DuPont Bifidus Sales by Application in 2024
11.2.7 DuPont Bifidus Sales by Geographic Area in 2024
11.2.8 DuPont Bifidus SWOT Analysis
11.2.9 DuPont Recent Developments
11.3 Wecare Probiotics
11.3.1 Wecare Probiotics Corporation Information
11.3.2 Wecare Probiotics Business Overview
11.3.3 Wecare Probiotics Bifidus Product Models, Descriptions and Specifications
11.3.4 Wecare Probiotics Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Wecare Probiotics Bifidus Sales by Product in 2024
11.3.6 Wecare Probiotics Bifidus Sales by Application in 2024
11.3.7 Wecare Probiotics Bifidus Sales by Geographic Area in 2024
11.3.8 Wecare Probiotics Bifidus SWOT Analysis
11.3.9 Wecare Probiotics Recent Developments
11.4 Probi
11.4.1 Probi Corporation Information
11.4.2 Probi Business Overview
11.4.3 Probi Bifidus Product Models, Descriptions and Specifications
11.4.4 Probi Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Probi Bifidus Sales by Product in 2024
11.4.6 Probi Bifidus Sales by Application in 2024
11.4.7 Probi Bifidus Sales by Geographic Area in 2024
11.4.8 Probi Bifidus SWOT Analysis
11.4.9 Probi Recent Developments
11.5 Mitushi Bio Pharma
11.5.1 Mitushi Bio Pharma Corporation Information
11.5.2 Mitushi Bio Pharma Business Overview
11.5.3 Mitushi Bio Pharma Bifidus Product Models, Descriptions and Specifications
11.5.4 Mitushi Bio Pharma Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Mitushi Bio Pharma Bifidus Sales by Product in 2024
11.5.6 Mitushi Bio Pharma Bifidus Sales by Application in 2024
11.5.7 Mitushi Bio Pharma Bifidus Sales by Geographic Area in 2024
11.5.8 Mitushi Bio Pharma Bifidus SWOT Analysis
11.5.9 Mitushi Bio Pharma Recent Developments
11.6 Scitop Bio-tech
11.6.1 Scitop Bio-tech Corporation Information
11.6.2 Scitop Bio-tech Business Overview
11.6.3 Scitop Bio-tech Bifidus Product Models, Descriptions and Specifications
11.6.4 Scitop Bio-tech Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Scitop Bio-tech Recent Developments
11.7 Lallemand
11.7.1 Lallemand Corporation Information
11.7.2 Lallemand Business Overview
11.7.3 Lallemand Bifidus Product Models, Descriptions and Specifications
11.7.4 Lallemand Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Lallemand Recent Developments
11.8 Goerlich Pharma
11.8.1 Goerlich Pharma Corporation Information
11.8.2 Goerlich Pharma Business Overview
11.8.3 Goerlich Pharma Bifidus Product Models, Descriptions and Specifications
11.8.4 Goerlich Pharma Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Goerlich Pharma Recent Developments
11.9 Shandong Zhongke Jiayi Bioengineering
11.9.1 Shandong Zhongke Jiayi Bioengineering Corporation Information
11.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview
11.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Product Models, Descriptions and Specifications
11.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments
11.10 Danone
11.10.1 Danone Corporation Information
11.10.2 Danone Business Overview
11.10.3 Danone Bifidus Product Models, Descriptions and Specifications
11.10.4 Danone Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Danone Recent Developments
11.11 Shanghai SPH Sinopharm
11.11.1 Shanghai SPH Sinopharm Corporation Information
11.11.2 Shanghai SPH Sinopharm Business Overview
11.11.3 Shanghai SPH Sinopharm Bifidus Product Models, Descriptions and Specifications
11.11.4 Shanghai SPH Sinopharm Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Shanghai SPH Sinopharm Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Bifidus Industry Chain
12.2 Bifidus Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Bifidus Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Bifidus Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bifidus Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bifidus Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Bifidus Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bifidus Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bifidus Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bifidus Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bifidus Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Bifidus Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Bifidus Sales by Region (2020-2025) & (K Units)
Table 8. Global Bifidus Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Bifidus Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Bifidus Sales Share by Manufacturers (2020-2025)
Table 12. Global Bifidus Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Bifidus Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Bifidus by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidus as of 2024)
Table 16. Global Bifidus Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Bifidus Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Bifidus Manufacturing Base and Headquarters
Table 19. Global Bifidus Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Bifidus Sales by Type (2020-2025) & (K Units)
Table 23. Global Bifidus Sales by Type (2026-2031) & (K Units)
Table 24. Global Bifidus Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Bifidus Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Bifidus ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Bifidus Sales by Application (2020-2025) & (K Units)
Table 29. Global Bifidus Sales by Application (2026-2031) & (K Units)
Table 30. Bifidus High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Bifidus Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Bifidus Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Bifidus ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Bifidus Growth Accelerators and Market Barriers
Table 37. North America Bifidus Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Bifidus Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Bifidus Growth Accelerators and Market Barriers
Table 40. Europe Bifidus Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Bifidus Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Bifidus Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Bifidus Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Bifidus Growth Accelerators and Market Barriers
Table 45. Southeast Asia Bifidus Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Bifidus Investment Opportunities and Key Challenges
Table 47. Central and South America Bifidus Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Bifidus Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Bifidus Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Chr-Hansen Corporation Information
Table 51. Chr-Hansen Description and Major Businesses
Table 52. Chr-Hansen Product Models, Descriptions and Specifications
Table 53. Chr-Hansen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Chr-Hansen Sales Value Proportion by Product in 2024
Table 55. Chr-Hansen Sales Value Proportion by Application in 2024
Table 56. Chr-Hansen Sales Value Proportion by Geographic Area in 2024
Table 57. Chr-Hansen Bifidus SWOT Analysis
Table 58. Chr-Hansen Recent Developments
Table 59. DuPont Corporation Information
Table 60. DuPont Description and Major Businesses
Table 61. DuPont Product Models, Descriptions and Specifications
Table 62. DuPont Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. DuPont Sales Value Proportion by Product in 2024
Table 64. DuPont Sales Value Proportion by Application in 2024
Table 65. DuPont Sales Value Proportion by Geographic Area in 2024
Table 66. DuPont Bifidus SWOT Analysis
Table 67. DuPont Recent Developments
Table 68. Wecare Probiotics Corporation Information
Table 69. Wecare Probiotics Description and Major Businesses
Table 70. Wecare Probiotics Product Models, Descriptions and Specifications
Table 71. Wecare Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Wecare Probiotics Sales Value Proportion by Product in 2024
Table 73. Wecare Probiotics Sales Value Proportion by Application in 2024
Table 74. Wecare Probiotics Sales Value Proportion by Geographic Area in 2024
Table 75. Wecare Probiotics Bifidus SWOT Analysis
Table 76. Wecare Probiotics Recent Developments
Table 77. Probi Corporation Information
Table 78. Probi Description and Major Businesses
Table 79. Probi Product Models, Descriptions and Specifications
Table 80. Probi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Probi Sales Value Proportion by Product in 2024
Table 82. Probi Sales Value Proportion by Application in 2024
Table 83. Probi Sales Value Proportion by Geographic Area in 2024
Table 84. Probi Bifidus SWOT Analysis
Table 85. Probi Recent Developments
Table 86. Mitushi Bio Pharma Corporation Information
Table 87. Mitushi Bio Pharma Description and Major Businesses
Table 88. Mitushi Bio Pharma Product Models, Descriptions and Specifications
Table 89. Mitushi Bio Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Mitushi Bio Pharma Sales Value Proportion by Product in 2024
Table 91. Mitushi Bio Pharma Sales Value Proportion by Application in 2024
Table 92. Mitushi Bio Pharma Sales Value Proportion by Geographic Area in 2024
Table 93. Mitushi Bio Pharma Bifidus SWOT Analysis
Table 94. Mitushi Bio Pharma Recent Developments
Table 95. Scitop Bio-tech Corporation Information
Table 96. Scitop Bio-tech Description and Major Businesses
Table 97. Scitop Bio-tech Product Models, Descriptions and Specifications
Table 98. Scitop Bio-tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Scitop Bio-tech Recent Developments
Table 100. Lallemand Corporation Information
Table 101. Lallemand Description and Major Businesses
Table 102. Lallemand Product Models, Descriptions and Specifications
Table 103. Lallemand Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Lallemand Recent Developments
Table 105. Goerlich Pharma Corporation Information
Table 106. Goerlich Pharma Description and Major Businesses
Table 107. Goerlich Pharma Product Models, Descriptions and Specifications
Table 108. Goerlich Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Goerlich Pharma Recent Developments
Table 110. Shandong Zhongke Jiayi Bioengineering Corporation Information
Table 111. Shandong Zhongke Jiayi Bioengineering Description and Major Businesses
Table 112. Shandong Zhongke Jiayi Bioengineering Product Models, Descriptions and Specifications
Table 113. Shandong Zhongke Jiayi Bioengineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Shandong Zhongke Jiayi Bioengineering Recent Developments
Table 115. Danone Corporation Information
Table 116. Danone Description and Major Businesses
Table 117. Danone Product Models, Descriptions and Specifications
Table 118. Danone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Danone Recent Developments
Table 120. Shanghai SPH Sinopharm Corporation Information
Table 121. Shanghai SPH Sinopharm Description and Major Businesses
Table 122. Shanghai SPH Sinopharm Product Models, Descriptions and Specifications
Table 123. Shanghai SPH Sinopharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Shanghai SPH Sinopharm Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Bifidus Product Picture
Figure 2. Global Bifidus Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Food Grade Product Picture
Figure 4. Pharmaceutical Grade Product Picture
Figure 5. Global Bifidus Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Food & Beverages
Figure 7. Medicines
Figure 8. Health Products
Figure 9. Others
Figure 10. Bifidus Report Years Considered
Figure 11. Global Bifidus Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Bifidus Revenue (2020-2031) & (US$ Million)
Figure 13. Global Bifidus Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Bifidus Revenue Market Share by Region (2020-2031)
Figure 15. Global Bifidus Sales (2020-2031) & (K Units)
Figure 16. Global Bifidus Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Bifidus Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Bifidus Sales Volume Market Share in 2024
Figure 19. Global Bifidus Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Food Grade Revenue Market Share by Manufacturer in 2024
Figure 22. Pharmaceutical Grade Revenue Market Share by Manufacturer in 2024
Figure 23. Global Bifidus Sales Market Share by Type (2020-2031)
Figure 24. Global Bifidus Revenue Market Share by Type (2020-2031)
Figure 25. Global Bifidus Sales Market Share by Application (2020-2031)
Figure 26. Global Bifidus Revenue Market Share by Application (2020-2031)
Figure 27. North America Bifidus Sales YoY (2020-2031) & (K Units)
Figure 28. North America Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 30. North America Bifidus Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Bifidus Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Bifidus Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Bifidus Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Bifidus Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Bifidus Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 40. Europe Bifidus Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Bifidus Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Bifidus Revenue (2020-2031) & (US$ Million)
Figure 45. France Bifidus Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Bifidus Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Bifidus Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Bifidus Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Bifidus Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Bifidus Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Bifidus Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Bifidus Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Bifidus Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Bifidus Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Bifidus Revenue (2020-2031) & (US$ Million)
Figure 60. India Bifidus Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Bifidus Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Bifidus Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Bifidus Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Bifidus Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Bifidus Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Bifidus Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Bifidus Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Bifidus Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Bifidus Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Bifidus Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Bifidus Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Bifidus Revenue (2020-2025) & (US$ Million)
Figure 81. Bifidus Industry Chain Mapping
Figure 82. Regional Bifidus Manufacturing Base Distribution (%)
Figure 83. Global Bifidus Production Market Share by Region (2020-2031)
Figure 84. Bifidus Production Process
Figure 85. Regional Bifidus Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Table 1. Global Bifidus Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bifidus Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bifidus Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bifidus Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bifidus Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Bifidus Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Bifidus Sales by Region (2020-2025) & (K Units)
Table 8. Global Bifidus Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Bifidus Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Bifidus Sales Share by Manufacturers (2020-2025)
Table 12. Global Bifidus Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Bifidus Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Bifidus by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidus as of 2024)
Table 16. Global Bifidus Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Bifidus Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Bifidus Manufacturing Base and Headquarters
Table 19. Global Bifidus Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Bifidus Sales by Type (2020-2025) & (K Units)
Table 23. Global Bifidus Sales by Type (2026-2031) & (K Units)
Table 24. Global Bifidus Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Bifidus Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Bifidus ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Bifidus Sales by Application (2020-2025) & (K Units)
Table 29. Global Bifidus Sales by Application (2026-2031) & (K Units)
Table 30. Bifidus High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Bifidus Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Bifidus Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Bifidus ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Bifidus Growth Accelerators and Market Barriers
Table 37. North America Bifidus Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Bifidus Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Bifidus Growth Accelerators and Market Barriers
Table 40. Europe Bifidus Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Bifidus Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Bifidus Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Bifidus Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Bifidus Growth Accelerators and Market Barriers
Table 45. Southeast Asia Bifidus Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Bifidus Investment Opportunities and Key Challenges
Table 47. Central and South America Bifidus Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Bifidus Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Bifidus Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Chr-Hansen Corporation Information
Table 51. Chr-Hansen Description and Major Businesses
Table 52. Chr-Hansen Product Models, Descriptions and Specifications
Table 53. Chr-Hansen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Chr-Hansen Sales Value Proportion by Product in 2024
Table 55. Chr-Hansen Sales Value Proportion by Application in 2024
Table 56. Chr-Hansen Sales Value Proportion by Geographic Area in 2024
Table 57. Chr-Hansen Bifidus SWOT Analysis
Table 58. Chr-Hansen Recent Developments
Table 59. DuPont Corporation Information
Table 60. DuPont Description and Major Businesses
Table 61. DuPont Product Models, Descriptions and Specifications
Table 62. DuPont Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. DuPont Sales Value Proportion by Product in 2024
Table 64. DuPont Sales Value Proportion by Application in 2024
Table 65. DuPont Sales Value Proportion by Geographic Area in 2024
Table 66. DuPont Bifidus SWOT Analysis
Table 67. DuPont Recent Developments
Table 68. Wecare Probiotics Corporation Information
Table 69. Wecare Probiotics Description and Major Businesses
Table 70. Wecare Probiotics Product Models, Descriptions and Specifications
Table 71. Wecare Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Wecare Probiotics Sales Value Proportion by Product in 2024
Table 73. Wecare Probiotics Sales Value Proportion by Application in 2024
Table 74. Wecare Probiotics Sales Value Proportion by Geographic Area in 2024
Table 75. Wecare Probiotics Bifidus SWOT Analysis
Table 76. Wecare Probiotics Recent Developments
Table 77. Probi Corporation Information
Table 78. Probi Description and Major Businesses
Table 79. Probi Product Models, Descriptions and Specifications
Table 80. Probi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Probi Sales Value Proportion by Product in 2024
Table 82. Probi Sales Value Proportion by Application in 2024
Table 83. Probi Sales Value Proportion by Geographic Area in 2024
Table 84. Probi Bifidus SWOT Analysis
Table 85. Probi Recent Developments
Table 86. Mitushi Bio Pharma Corporation Information
Table 87. Mitushi Bio Pharma Description and Major Businesses
Table 88. Mitushi Bio Pharma Product Models, Descriptions and Specifications
Table 89. Mitushi Bio Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Mitushi Bio Pharma Sales Value Proportion by Product in 2024
Table 91. Mitushi Bio Pharma Sales Value Proportion by Application in 2024
Table 92. Mitushi Bio Pharma Sales Value Proportion by Geographic Area in 2024
Table 93. Mitushi Bio Pharma Bifidus SWOT Analysis
Table 94. Mitushi Bio Pharma Recent Developments
Table 95. Scitop Bio-tech Corporation Information
Table 96. Scitop Bio-tech Description and Major Businesses
Table 97. Scitop Bio-tech Product Models, Descriptions and Specifications
Table 98. Scitop Bio-tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Scitop Bio-tech Recent Developments
Table 100. Lallemand Corporation Information
Table 101. Lallemand Description and Major Businesses
Table 102. Lallemand Product Models, Descriptions and Specifications
Table 103. Lallemand Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Lallemand Recent Developments
Table 105. Goerlich Pharma Corporation Information
Table 106. Goerlich Pharma Description and Major Businesses
Table 107. Goerlich Pharma Product Models, Descriptions and Specifications
Table 108. Goerlich Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Goerlich Pharma Recent Developments
Table 110. Shandong Zhongke Jiayi Bioengineering Corporation Information
Table 111. Shandong Zhongke Jiayi Bioengineering Description and Major Businesses
Table 112. Shandong Zhongke Jiayi Bioengineering Product Models, Descriptions and Specifications
Table 113. Shandong Zhongke Jiayi Bioengineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Shandong Zhongke Jiayi Bioengineering Recent Developments
Table 115. Danone Corporation Information
Table 116. Danone Description and Major Businesses
Table 117. Danone Product Models, Descriptions and Specifications
Table 118. Danone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Danone Recent Developments
Table 120. Shanghai SPH Sinopharm Corporation Information
Table 121. Shanghai SPH Sinopharm Description and Major Businesses
Table 122. Shanghai SPH Sinopharm Product Models, Descriptions and Specifications
Table 123. Shanghai SPH Sinopharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Shanghai SPH Sinopharm Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Bifidus Product Picture
Figure 2. Global Bifidus Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Food Grade Product Picture
Figure 4. Pharmaceutical Grade Product Picture
Figure 5. Global Bifidus Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Food & Beverages
Figure 7. Medicines
Figure 8. Health Products
Figure 9. Others
Figure 10. Bifidus Report Years Considered
Figure 11. Global Bifidus Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Bifidus Revenue (2020-2031) & (US$ Million)
Figure 13. Global Bifidus Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Bifidus Revenue Market Share by Region (2020-2031)
Figure 15. Global Bifidus Sales (2020-2031) & (K Units)
Figure 16. Global Bifidus Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Bifidus Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Bifidus Sales Volume Market Share in 2024
Figure 19. Global Bifidus Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Food Grade Revenue Market Share by Manufacturer in 2024
Figure 22. Pharmaceutical Grade Revenue Market Share by Manufacturer in 2024
Figure 23. Global Bifidus Sales Market Share by Type (2020-2031)
Figure 24. Global Bifidus Revenue Market Share by Type (2020-2031)
Figure 25. Global Bifidus Sales Market Share by Application (2020-2031)
Figure 26. Global Bifidus Revenue Market Share by Application (2020-2031)
Figure 27. North America Bifidus Sales YoY (2020-2031) & (K Units)
Figure 28. North America Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 30. North America Bifidus Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Bifidus Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Bifidus Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Bifidus Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Bifidus Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Bifidus Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 40. Europe Bifidus Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Bifidus Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Bifidus Revenue (2020-2031) & (US$ Million)
Figure 45. France Bifidus Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Bifidus Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Bifidus Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Bifidus Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Bifidus Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Bifidus Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Bifidus Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Bifidus Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Bifidus Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Bifidus Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Bifidus Revenue (2020-2031) & (US$ Million)
Figure 60. India Bifidus Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Bifidus Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Bifidus Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Bifidus Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Bifidus Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Bifidus Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Bifidus Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Bifidus Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Bifidus Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Bifidus Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Bifidus Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Bifidus Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Bifidus Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Bifidus Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Bifidus Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Bifidus Revenue (2020-2025) & (US$ Million)
Figure 81. Bifidus Industry Chain Mapping
Figure 82. Regional Bifidus Manufacturing Base Distribution (%)
Figure 83. Global Bifidus Production Market Share by Region (2020-2031)
Figure 84. Bifidus Production Process
Figure 85. Regional Bifidus Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Motor Brush Rocker Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 16, 25
Global Pediatric Mandibular Distractor System Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 16, 25
Global Automatic Coercive Force Meter Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232